G6PD and hepatocellular carcinoma: Given its involvement in glucose metabolism and redox regulation, G6PD represents a potential prognostic biomarker and therapeutic target in HCC, with inhibitors of G6PD or the pentose phosphate pathway offering promising avenues for treatment.